array:24 [
  "pii" => "S0873215915301562"
  "issn" => "08732159"
  "doi" => "10.1016/S0873-2159(15)30156-2"
  "estado" => "S350"
  "fechaPublicacion" => "2009-05-01"
  "aid" => "18"
  "copyright" => "Sociedade Portuguesa de Pneumologia/SPP"
  "copyrightAnyo" => "2009"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Rev Port Pneumol. 2009;15:560-6"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1760
    "formatos" => array:3 [
      "EPUB" => 199
      "HTML" => 898
      "PDF" => 663
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0873215915301458"
    "issn" => "08732159"
    "doi" => "10.1016/S0873-2159(15)30145-8"
    "estado" => "S350"
    "fechaPublicacion" => "2009-05-01"
    "aid" => "7"
    "copyright" => "Sociedade Portuguesa de Pneumologia/SPP"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "rev"
    "cita" => "Rev Port Pneumol. 2009;15:443-60"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2229
      "formatos" => array:3 [
        "EPUB" => 231
        "HTML" => 1247
        "PDF" => 751
      ]
    ]
    "pt" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo de Revis&#227;o&#47;Review Article</span>"
      "titulo" => "Avalia&#231;&#227;o da inflama&#231;&#227;o das vias a&#233;reas&#46; Vias &#225;reas superiores e compartimento broncopulmonar"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "pt"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "443"
          "paginaFinal" => "460"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Airways inflammation evaluation&#46; Upper and lower airways"
        ]
      ]
      "contieneResumen" => array:2 [
        "pt" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Lu&#237;sa Geraldes, Ana Todo-Bom, Carlos Loureiro"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Lu&#237;sa"
              "apellidos" => "Geraldes"
            ]
            1 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Todo-Bom"
            ]
            2 => array:2 [
              "nombre" => "Carlos"
              "apellidos" => "Loureiro"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915301458?idApp=UINPBA00004E"
    "url" => "/08732159/0000001500000003/v1_201509151500/S0873215915301458/v1_201509151500/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0873215915301446"
    "issn" => "08732159"
    "doi" => "10.1016/S0873-2159(15)30144-6"
    "estado" => "S350"
    "fechaPublicacion" => "2009-05-01"
    "aid" => "6"
    "copyright" => "Sociedade Portuguesa de Pneumologia&#47;SPP"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2009;15:433-42"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2117
      "formatos" => array:3 [
        "EPUB" => 220
        "HTML" => 1218
        "PDF" => 679
      ]
    ]
    "pt" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original&#47;Original Article</span>"
      "titulo" => "Doen&#231;as pulmonares intersticiais&#58; Acuidade diagn&#243;stica e riscos da bi&#243;psia pulmonar cir&#250;rgica"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "pt"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "433"
          "paginaFinal" => "442"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Interstitial lung disease&#58; Diagnostic accuracy and safety of surgical lung biopsy"
        ]
      ]
      "contieneResumen" => array:2 [
        "pt" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Miguel Guerra, Jos&#233; Ant&#243;nio Miranda, Francisco Leal, Lu&#237;s Vouga"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Miguel"
              "apellidos" => "Guerra"
            ]
            1 => array:2 [
              "nombre" => "Jos&#233; Ant&#243;nio"
              "apellidos" => "Miranda"
            ]
            2 => array:2 [
              "nombre" => "Francisco"
              "apellidos" => "Leal"
            ]
            3 => array:2 [
              "nombre" => "Lu&#237;s"
              "apellidos" => "Vouga"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915301446?idApp=UINPBA00004E"
    "url" => "/08732159/0000001500000003/v1_201509151500/S0873215915301446/v1_201509151500/pt/main.assets"
  ]
  "pt" => array:9 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Resposta ao Editor&#47;Reply to the Editor</span>"
    "titulo" => "Ara&#250;jo A&#44; <span class="elsevierStyleItalic">et al&#46;</span> Avalia&#231;&#227;o econ&#243;mica do erlotinib&#44; docetaxel&#44; pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803-827"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "560"
        "paginaFinal" => "566"
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Ara&#250;jo A&#44; et al&#46; An economic analysis of erlotinib&#44; docetaxel&#44; pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803-827"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "lecturaRecomendada" => array:1 [
      0 => array:3 [
        "vista" => "all"
        "titulo" => "<span class="elsevierStyleSectionTitle" id="st0005">Bibliografia&#47;Bibliography</span>"
        "seccion" => array:1 [
          0 => array:2 [
            "vista" => "all"
            "bibliografiaReferencia" => array:17 [
              0 => array:3 [
                "identificador" => "bb0005"
                "etiqueta" => "1&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Avalia&#231;&#227;o econ&#243;mica do erlotinib&#44; docetaxel&#44; pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:1 [
                              0 => "A&#46; Ara&#250;jo"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:7 [
                          "tituloSerie" => "Rev Port Pneumol"
                          "fecha" => "2008"
                          "volumen" => "14"
                          "numero" => "6"
                          "paginaInicial" => "803"
                          "paginaFinal" => "827"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19023496"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              1 => array:3 [
                "identificador" => "bb0010"
                "etiqueta" => "2&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Practice Guidelines in Oncology &#8211; v&#46;2&#46;2009 Non-Small Cell Lung Cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:1 [
                              0 => "National Comprehensive Cancer Network"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "WWW" => array:1 [
                          "link" => "http&#58;&#47;&#47;www&#46;nccn&#46;org&#47;professional&#47;physician&#95;gls&#47;f&#95;guidelines&#46;asp"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              2 => array:3 [
                "identificador" => "bb0015"
                "etiqueta" => "3&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Updated guide to the methods of technology appraisal"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:1 [
                              0 => "National Institute for Health and Clinical Excellence"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "WWW" => array:2 [
                          "link" => "http&#58;&#47;&#47;nice&#46;org&#46;uk&#47;media&#47;B52&#47;A7&#47;TAMethodsGuideUpsdatedJune2008&#46;pdf"
                          "fecha" => "June 2008"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              3 => array:3 [
                "identificador" => "bb0020"
                "etiqueta" => "4&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Erlotinib in previously treated non-small cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "F&#46;A&#46; Shepherd"
                              1 => "J&#46; Pereira"
                              2 => "T&#46; Ciuleanu"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:2 [
                        "doi" => "10.1056/NEJMoa050753"
                        "Revista" => array:6 [
                          "tituloSerie" => "N Engl J Med"
                          "fecha" => "2005"
                          "volumen" => "353"
                          "paginaInicial" => "123"
                          "paginaFinal" => "132"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16014882"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              4 => array:3 [
                "identificador" => "bb0025"
                "etiqueta" => "5&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based therapy"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:1 [
                              0 => "F&#46;A&#46; Shepherd"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:2 [
                        "doi" => "10.1200/jco.2000.18.10.2095"
                        "Revista" => array:6 [
                          "tituloSerie" => "J Clin Oncol"
                          "fecha" => "2000"
                          "volumen" => "18"
                          "numero" => "10"
                          "paginaInicial" => "2095"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10811675"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              5 => array:3 [
                "identificador" => "bb0030"
                "etiqueta" => "6&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "N&#46; Hanna"
                              1 => "F&#46;A&#46; Shepherd"
                              2 => "F&#46;V&#46; Fossela"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:2 [
                        "doi" => "10.1200/JCO.2004.08.163"
                        "Revista" => array:6 [
                          "tituloSerie" => "J Clin Oncol"
                          "fecha" => "2004"
                          "volumen" => "22"
                          "paginaInicial" => "1589"
                          "paginaFinal" => "1597"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15117980"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              6 => array:3 [
                "identificador" => "bb0035"
                "etiqueta" => "7&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "A comparison of the estimated costs of erlotinib&#44; docetaxel and pemetrexed for the second-line treatment of non-small cell lung cancer from the German healthcare perspective"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "W&#46; Kotowa"
                              1 => "U&#46; Gatzemeier"
                              2 => "O&#46; Pirk"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:5 [
                          "tituloSerie" => "Journal of Medical Economics"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "255"
                          "paginaFinal" => "271"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              7 => array:3 [
                "identificador" => "bb0040"
                "etiqueta" => "8&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Pemetrexed for the treatment of non-small-cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:1 [
                              0 => "National Institute for Health and Clinical Excellence"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "WWW" => array:2 [
                          "link" => "http&#58;&#47;&#47;www&#46;nice&#46;org&#46;uk&#47;TA124"
                          "fecha" => "August 2007"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              8 => array:3 [
                "identificador" => "bb0045"
                "etiqueta" => "9&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Chemotherapeutic management of stage IV non-small cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:4 [
                              0 => "M&#46;A&#46; Socinski"
                              1 => "D&#46;E&#46; Morris"
                              2 => "G&#46;A&#46; Masters"
                              3 => "R&#46; Lilenbaum"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:5 [
                          "tituloSerie" => "Chest"
                          "fecha" => "2003"
                          "volumen" => "123"
                          "paginaInicial" => "226"
                          "paginaFinal" => "243"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              9 => array:3 [
                "identificador" => "bb0050"
                "etiqueta" => "10&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "New avenues for second-line treatment of metastatic non-small-cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "C&#46; Gridelli"
                              1 => "P&#46; Maione"
                              2 => "A&#46; Rossi"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:2 [
                        "doi" => "10.1586/14737140.9.1.115"
                        "Revista" => array:7 [
                          "tituloSerie" => "Expert Rev Anticancer Ther"
                          "fecha" => "2009"
                          "volumen" => "9"
                          "numero" => "1"
                          "paginaInicial" => "115"
                          "paginaFinal" => "124"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19105711"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              10 => array:3 [
                "identificador" => "bb0055"
                "etiqueta" => "11&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Considerations for second-line therapy of non-small cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:2 [
                              0 => "T&#46;E&#46; Stinchcombe"
                              1 => "M&#46;A&#46; Socinski"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "On-cologist"
                          "fecha" => "2008"
                          "volumen" => "13"
                          "numero" => "Suppl 1"
                          "paginaInicial" => "28"
                          "paginaFinal" => "36"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              11 => array:3 [
                "identificador" => "bb0060"
                "etiqueta" => "12&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Cost-effectiveness of erlotinib <span class="elsevierStyleItalic">vs</span> docetaxel or pemetrexed in the treatment of refractory non-small cell lung cancer &#40;NSCLC&#41;"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "J&#46; Carlson"
                              1 => "N&#46; Oestreicher"
                              2 => "D&#46;P&#46; Lubeck"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:5 [
                          "tituloSerie" => "Journal of Clinical Oncology"
                          "fecha" => "2007"
                          "volumen" => "25"
                          "numero" => "Suppl 18"
                          "paginaInicial" => "425"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              12 => array:3 [
                "identificador" => "bb0065"
                "etiqueta" => "13&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Economic impact of second- and third-line erlotinib treatment of non small-cell lung cancer&#58; a French observational study"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "C&#46; Chouaid"
                              1 => "A&#46; Vergnenegre"
                              2 => "A&#46; Moser"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:4 [
                          "tituloSerie" => "Value in Health"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "A322"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              13 => array:3 [
                "identificador" => "bb0070"
                "etiqueta" => "14&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Economic evaluation of erlotinib&#44; docetaxel and pemetrexed as second line treatment in patients with advanced non-small-cell lung cancer &#40;NSCLC&#41;&#58; A cost-minimization in Italian hospitals"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "S&#46; Capri"
                              1 => "A&#46; Morabito"
                              2 => "G&#46; Carillio"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:5 [
                          "tituloSerie" => "Value in Health"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "A333"
                          "itemHostRev" => array:3 [
                            "pii" => "S0165032713008598"
                            "estado" => "S300"
                            "issn" => "01650327"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              14 => array:3 [
                "identificador" => "bb0075"
                "etiqueta" => "15&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Cost-minimization analysis of erlotinib versus docetaxel or pemetrexed as second-line therapy for non-small-cell lung cancer &#40;NSCLC&#41; from the perspective of a private payer in Brazil"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:3 [
                              0 => "S&#46; Stefani"
                              1 => "M&#46;G&#46; Saggia"
                              2 => "E&#46;A&#46; Santos"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:4 [
                          "tituloSerie" => "Value in Health"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "A332k"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              15 => array:3 [
                "identificador" => "bb0080"
                "etiqueta" => "16&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Cost-effectiveness analysis of erlotinib compared with docetaxel and pemetrexed for second-line treatment of advanced non-small cell lung cancer &#40;NSCLC&#41; in Taiwan"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "T&#46;C&#46; Hsia"
                              1 => "G&#46;C&#46; Chang"
                              2 => "Y&#46;M&#46; Chen"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:4 [
                          "tituloSerie" => "Value in Health"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "A325"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              16 => array:3 [
                "identificador" => "bb0085"
                "etiqueta" => "17&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Pharmacoeconomic analysis of erlotinib compared with docetaxel for the treatment of relapsed non-small-cell lung cancer &#40;NSCLC&#41; in Turkey&#46; PCN77"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:2 [
                              0 => "O&#46; Batigun"
                              1 => "E&#46; Yildrim"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:4 [
                          "tituloSerie" => "Value in Health"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "A234"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/08732159/0000001500000003/v1_201509151500/S0873215915301562/v1_201509151500/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "43855"
    "tipo" => "SECCION"
    "pt" => array:2 [
      "titulo" => "Resposta ao Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "pt"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/08732159/0000001500000003/v1_201509151500/S0873215915301562/v1_201509151500/pt/main.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915301562?idApp=UINPBA00004E"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Resposta ao Editor/Reply to the Editor
Araújo A, et al. Avaliação económica do erlotinib, docetaxel, pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulmão de não pequenas células Rev Port Pneumol 2008; 14(6):803-827
Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008; 14(6):803-827
Read
4646
Times
was read the article
2299
Total PDF
2347
Total HTML
Share statistics
 array:24 [
  "pii" => "S0873215915301562"
  "issn" => "08732159"
  "doi" => "10.1016/S0873-2159(15)30156-2"
  "estado" => "S350"
  "fechaPublicacion" => "2009-05-01"
  "aid" => "18"
  "copyright" => "Sociedade Portuguesa de Pneumologia&#47;SPP"
  "copyrightAnyo" => "2009"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Rev Port Pneumol. 2009;15:560-6"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1760
    "formatos" => array:3 [
      "EPUB" => 199
      "HTML" => 898
      "PDF" => 663
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0873215915301458"
    "issn" => "08732159"
    "doi" => "10.1016/S0873-2159(15)30145-8"
    "estado" => "S350"
    "fechaPublicacion" => "2009-05-01"
    "aid" => "7"
    "copyright" => "Sociedade Portuguesa de Pneumologia&#47;SPP"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "rev"
    "cita" => "Rev Port Pneumol. 2009;15:443-60"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2229
      "formatos" => array:3 [
        "EPUB" => 231
        "HTML" => 1247
        "PDF" => 751
      ]
    ]
    "pt" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo de Revis&#227;o&#47;Review Article</span>"
      "titulo" => "Avalia&#231;&#227;o da inflama&#231;&#227;o das vias a&#233;reas&#46; Vias &#225;reas superiores e compartimento broncopulmonar"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "pt"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "443"
          "paginaFinal" => "460"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Airways inflammation evaluation&#46; Upper and lower airways"
        ]
      ]
      "contieneResumen" => array:2 [
        "pt" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Lu&#237;sa Geraldes, Ana Todo-Bom, Carlos Loureiro"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Lu&#237;sa"
              "apellidos" => "Geraldes"
            ]
            1 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Todo-Bom"
            ]
            2 => array:2 [
              "nombre" => "Carlos"
              "apellidos" => "Loureiro"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915301458?idApp=UINPBA00004E"
    "url" => "/08732159/0000001500000003/v1_201509151500/S0873215915301458/v1_201509151500/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0873215915301446"
    "issn" => "08732159"
    "doi" => "10.1016/S0873-2159(15)30144-6"
    "estado" => "S350"
    "fechaPublicacion" => "2009-05-01"
    "aid" => "6"
    "copyright" => "Sociedade Portuguesa de Pneumologia&#47;SPP"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2009;15:433-42"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2117
      "formatos" => array:3 [
        "EPUB" => 220
        "HTML" => 1218
        "PDF" => 679
      ]
    ]
    "pt" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original&#47;Original Article</span>"
      "titulo" => "Doen&#231;as pulmonares intersticiais&#58; Acuidade diagn&#243;stica e riscos da bi&#243;psia pulmonar cir&#250;rgica"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "pt"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "433"
          "paginaFinal" => "442"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Interstitial lung disease&#58; Diagnostic accuracy and safety of surgical lung biopsy"
        ]
      ]
      "contieneResumen" => array:2 [
        "pt" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Miguel Guerra, Jos&#233; Ant&#243;nio Miranda, Francisco Leal, Lu&#237;s Vouga"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Miguel"
              "apellidos" => "Guerra"
            ]
            1 => array:2 [
              "nombre" => "Jos&#233; Ant&#243;nio"
              "apellidos" => "Miranda"
            ]
            2 => array:2 [
              "nombre" => "Francisco"
              "apellidos" => "Leal"
            ]
            3 => array:2 [
              "nombre" => "Lu&#237;s"
              "apellidos" => "Vouga"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915301446?idApp=UINPBA00004E"
    "url" => "/08732159/0000001500000003/v1_201509151500/S0873215915301446/v1_201509151500/pt/main.assets"
  ]
  "pt" => array:9 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Resposta ao Editor&#47;Reply to the Editor</span>"
    "titulo" => "Ara&#250;jo A&#44; <span class="elsevierStyleItalic">et al&#46;</span> Avalia&#231;&#227;o econ&#243;mica do erlotinib&#44; docetaxel&#44; pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803-827"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "560"
        "paginaFinal" => "566"
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Ara&#250;jo A&#44; et al&#46; An economic analysis of erlotinib&#44; docetaxel&#44; pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803-827"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "lecturaRecomendada" => array:1 [
      0 => array:3 [
        "vista" => "all"
        "titulo" => "<span class="elsevierStyleSectionTitle" id="st0005">Bibliografia&#47;Bibliography</span>"
        "seccion" => array:1 [
          0 => array:2 [
            "vista" => "all"
            "bibliografiaReferencia" => array:17 [
              0 => array:3 [
                "identificador" => "bb0005"
                "etiqueta" => "1&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Avalia&#231;&#227;o econ&#243;mica do erlotinib&#44; docetaxel&#44; pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:1 [
                              0 => "A&#46; Ara&#250;jo"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:7 [
                          "tituloSerie" => "Rev Port Pneumol"
                          "fecha" => "2008"
                          "volumen" => "14"
                          "numero" => "6"
                          "paginaInicial" => "803"
                          "paginaFinal" => "827"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19023496"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              1 => array:3 [
                "identificador" => "bb0010"
                "etiqueta" => "2&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Practice Guidelines in Oncology &#8211; v&#46;2&#46;2009 Non-Small Cell Lung Cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:1 [
                              0 => "National Comprehensive Cancer Network"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "WWW" => array:1 [
                          "link" => "http&#58;&#47;&#47;www&#46;nccn&#46;org&#47;professional&#47;physician&#95;gls&#47;f&#95;guidelines&#46;asp"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              2 => array:3 [
                "identificador" => "bb0015"
                "etiqueta" => "3&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Updated guide to the methods of technology appraisal"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:1 [
                              0 => "National Institute for Health and Clinical Excellence"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "WWW" => array:2 [
                          "link" => "http&#58;&#47;&#47;nice&#46;org&#46;uk&#47;media&#47;B52&#47;A7&#47;TAMethodsGuideUpsdatedJune2008&#46;pdf"
                          "fecha" => "June 2008"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              3 => array:3 [
                "identificador" => "bb0020"
                "etiqueta" => "4&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Erlotinib in previously treated non-small cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "F&#46;A&#46; Shepherd"
                              1 => "J&#46; Pereira"
                              2 => "T&#46; Ciuleanu"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:2 [
                        "doi" => "10.1056/NEJMoa050753"
                        "Revista" => array:6 [
                          "tituloSerie" => "N Engl J Med"
                          "fecha" => "2005"
                          "volumen" => "353"
                          "paginaInicial" => "123"
                          "paginaFinal" => "132"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16014882"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              4 => array:3 [
                "identificador" => "bb0025"
                "etiqueta" => "5&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based therapy"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:1 [
                              0 => "F&#46;A&#46; Shepherd"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:2 [
                        "doi" => "10.1200/jco.2000.18.10.2095"
                        "Revista" => array:6 [
                          "tituloSerie" => "J Clin Oncol"
                          "fecha" => "2000"
                          "volumen" => "18"
                          "numero" => "10"
                          "paginaInicial" => "2095"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10811675"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              5 => array:3 [
                "identificador" => "bb0030"
                "etiqueta" => "6&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "N&#46; Hanna"
                              1 => "F&#46;A&#46; Shepherd"
                              2 => "F&#46;V&#46; Fossela"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:2 [
                        "doi" => "10.1200/JCO.2004.08.163"
                        "Revista" => array:6 [
                          "tituloSerie" => "J Clin Oncol"
                          "fecha" => "2004"
                          "volumen" => "22"
                          "paginaInicial" => "1589"
                          "paginaFinal" => "1597"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15117980"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              6 => array:3 [
                "identificador" => "bb0035"
                "etiqueta" => "7&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "A comparison of the estimated costs of erlotinib&#44; docetaxel and pemetrexed for the second-line treatment of non-small cell lung cancer from the German healthcare perspective"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "W&#46; Kotowa"
                              1 => "U&#46; Gatzemeier"
                              2 => "O&#46; Pirk"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:5 [
                          "tituloSerie" => "Journal of Medical Economics"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "255"
                          "paginaFinal" => "271"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              7 => array:3 [
                "identificador" => "bb0040"
                "etiqueta" => "8&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Pemetrexed for the treatment of non-small-cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:1 [
                              0 => "National Institute for Health and Clinical Excellence"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "WWW" => array:2 [
                          "link" => "http&#58;&#47;&#47;www&#46;nice&#46;org&#46;uk&#47;TA124"
                          "fecha" => "August 2007"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              8 => array:3 [
                "identificador" => "bb0045"
                "etiqueta" => "9&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Chemotherapeutic management of stage IV non-small cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:4 [
                              0 => "M&#46;A&#46; Socinski"
                              1 => "D&#46;E&#46; Morris"
                              2 => "G&#46;A&#46; Masters"
                              3 => "R&#46; Lilenbaum"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:5 [
                          "tituloSerie" => "Chest"
                          "fecha" => "2003"
                          "volumen" => "123"
                          "paginaInicial" => "226"
                          "paginaFinal" => "243"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              9 => array:3 [
                "identificador" => "bb0050"
                "etiqueta" => "10&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "New avenues for second-line treatment of metastatic non-small-cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "C&#46; Gridelli"
                              1 => "P&#46; Maione"
                              2 => "A&#46; Rossi"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:2 [
                        "doi" => "10.1586/14737140.9.1.115"
                        "Revista" => array:7 [
                          "tituloSerie" => "Expert Rev Anticancer Ther"
                          "fecha" => "2009"
                          "volumen" => "9"
                          "numero" => "1"
                          "paginaInicial" => "115"
                          "paginaFinal" => "124"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19105711"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              10 => array:3 [
                "identificador" => "bb0055"
                "etiqueta" => "11&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Considerations for second-line therapy of non-small cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:2 [
                              0 => "T&#46;E&#46; Stinchcombe"
                              1 => "M&#46;A&#46; Socinski"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "On-cologist"
                          "fecha" => "2008"
                          "volumen" => "13"
                          "numero" => "Suppl 1"
                          "paginaInicial" => "28"
                          "paginaFinal" => "36"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              11 => array:3 [
                "identificador" => "bb0060"
                "etiqueta" => "12&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Cost-effectiveness of erlotinib <span class="elsevierStyleItalic">vs</span> docetaxel or pemetrexed in the treatment of refractory non-small cell lung cancer &#40;NSCLC&#41;"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "J&#46; Carlson"
                              1 => "N&#46; Oestreicher"
                              2 => "D&#46;P&#46; Lubeck"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:5 [
                          "tituloSerie" => "Journal of Clinical Oncology"
                          "fecha" => "2007"
                          "volumen" => "25"
                          "numero" => "Suppl 18"
                          "paginaInicial" => "425"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              12 => array:3 [
                "identificador" => "bb0065"
                "etiqueta" => "13&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Economic impact of second- and third-line erlotinib treatment of non small-cell lung cancer&#58; a French observational study"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "C&#46; Chouaid"
                              1 => "A&#46; Vergnenegre"
                              2 => "A&#46; Moser"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:4 [
                          "tituloSerie" => "Value in Health"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "A322"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              13 => array:3 [
                "identificador" => "bb0070"
                "etiqueta" => "14&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Economic evaluation of erlotinib&#44; docetaxel and pemetrexed as second line treatment in patients with advanced non-small-cell lung cancer &#40;NSCLC&#41;&#58; A cost-minimization in Italian hospitals"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "S&#46; Capri"
                              1 => "A&#46; Morabito"
                              2 => "G&#46; Carillio"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:5 [
                          "tituloSerie" => "Value in Health"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "A333"
                          "itemHostRev" => array:3 [
                            "pii" => "S0165032713008598"
                            "estado" => "S300"
                            "issn" => "01650327"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              14 => array:3 [
                "identificador" => "bb0075"
                "etiqueta" => "15&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Cost-minimization analysis of erlotinib versus docetaxel or pemetrexed as second-line therapy for non-small-cell lung cancer &#40;NSCLC&#41; from the perspective of a private payer in Brazil"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:3 [
                              0 => "S&#46; Stefani"
                              1 => "M&#46;G&#46; Saggia"
                              2 => "E&#46;A&#46; Santos"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:4 [
                          "tituloSerie" => "Value in Health"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "A332k"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              15 => array:3 [
                "identificador" => "bb0080"
                "etiqueta" => "16&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Cost-effectiveness analysis of erlotinib compared with docetaxel and pemetrexed for second-line treatment of advanced non-small cell lung cancer &#40;NSCLC&#41; in Taiwan"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "T&#46;C&#46; Hsia"
                              1 => "G&#46;C&#46; Chang"
                              2 => "Y&#46;M&#46; Chen"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:4 [
                          "tituloSerie" => "Value in Health"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "A325"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              16 => array:3 [
                "identificador" => "bb0085"
                "etiqueta" => "17&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Pharmacoeconomic analysis of erlotinib compared with docetaxel for the treatment of relapsed non-small-cell lung cancer &#40;NSCLC&#41; in Turkey&#46; PCN77"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:2 [
                              0 => "O&#46; Batigun"
                              1 => "E&#46; Yildrim"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:4 [
                          "tituloSerie" => "Value in Health"
                          "fecha" => "2007"
                          "volumen" => "10"
                          "paginaInicial" => "A234"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/08732159/0000001500000003/v1_201509151500/S0873215915301562/v1_201509151500/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "43855"
    "tipo" => "SECCION"
    "pt" => array:2 [
      "titulo" => "Resposta ao Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "pt"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/08732159/0000001500000003/v1_201509151500/S0873215915301562/v1_201509151500/pt/main.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915301562?idApp=UINPBA00004E"
]
Article information
ISSN: 08732159
Original language: Portuguese
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 4 3 7
2024 October 42 32 74
2024 September 22 33 55
2024 August 35 33 68
2024 July 32 31 63
2024 June 19 26 45
2024 May 21 42 63
2024 April 26 29 55
2024 March 25 19 44
2024 February 18 30 48
2024 January 23 26 49
2023 December 26 23 49
2023 November 12 21 33
2023 October 15 26 41
2023 September 20 33 53
2023 August 18 25 43
2023 July 21 30 51
2023 June 11 14 25
2023 May 19 27 46
2023 April 24 17 41
2023 March 18 29 47
2023 February 15 36 51
2023 January 23 22 45
2022 December 17 28 45
2022 November 32 41 73
2022 October 26 32 58
2022 September 25 29 54
2022 August 35 72 107
2022 July 20 52 72
2022 June 24 32 56
2022 May 31 46 77
2022 April 23 39 62
2022 March 30 26 56
2022 February 23 26 49
2022 January 22 38 60
2021 December 17 37 54
2021 November 32 32 64
2021 October 23 43 66
2021 September 18 37 55
2021 August 19 29 48
2021 July 40 22 62
2021 June 18 40 58
2021 May 28 36 64
2021 April 33 41 74
2021 March 34 17 51
2021 February 49 20 69
2021 January 19 17 36
2020 December 19 7 26
2020 November 40 19 59
2020 October 10 27 37
2020 September 41 22 63
2020 August 42 21 63
2020 July 34 17 51
2020 June 37 20 57
2020 May 34 26 60
2020 April 31 23 54
2020 March 21 6 27
2020 February 30 40 70
2020 January 25 18 43
2019 December 26 23 49
2019 November 33 10 43
2019 October 28 17 45
2019 September 30 23 53
2019 August 30 14 44
2019 July 18 17 35
2019 June 20 27 47
2019 May 20 32 52
2019 April 27 44 71
2019 March 22 17 39
2019 February 22 12 34
2019 January 18 18 36
2018 December 24 10 34
2018 November 0 2 2
2018 October 3 9 12
2018 September 7 7 14
2018 August 22 27 49
2018 July 30 28 58
2018 June 36 15 51
2018 May 33 12 45
2018 April 29 25 54
2018 March 35 27 62
2018 February 16 4 20
2018 January 19 10 29
2017 December 23 12 35
2017 November 39 11 50
2017 October 17 10 27
2017 September 16 8 24
2017 August 23 10 33
2017 July 9 5 14
2017 June 22 10 32
2017 May 30 11 41
2017 April 12 10 22
2017 March 18 17 35
2017 February 11 3 14
2017 January 13 2 15
2016 December 11 4 15
2016 November 7 3 10
2016 October 14 10 24
2016 September 3 2 5
2016 August 2 5 7
2016 July 3 3 6
2016 June 0 10 10
2016 May 1 0 1
2016 April 2 3 5
2016 March 3 10 13
2016 February 4 10 14
2016 January 9 6 15
2015 December 12 4 16
2015 November 2 1 3
2015 October 2 4 6
Show all

Follow this link to access the full text of the article

Pulmonology

Are you a health professional able to prescribe or dispense drugs?